Go to the Table of Contents

Search tables for keyword
Please note: A selected table may take a few minutes to load.

210609
Table 11.1A – Settings Where Mental Health Services Were Received in Past Year: Among People Aged 12 to 17; Numbers in Thousands, 2002-2020
Setting Where Mental Health Service
Was Received		 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
SPECIALTY MENTAL HEALTH SERVICE1 2,898 3,065 3,348 3,362 3,255 3,104 3,129 2,925 2,920 3,101 3,118 3,341 3,369 3,253 3,598 3,646 3,901 4,088 4,246
Outpatient 2,662 2,795 3,015 3,048 2,931 2,787 2,837 2,650 2,635 2,842 2,846 3,064 3,110 2,958 3,239 3,328 3,547 3,747 4,088
Private Therapist, Psychologist,
   Psychiatrist, Social Worker, or
   Counselor		 2,254 2,347 2,523 2,573 2,416 2,365 2,408 2,296 2,265 2,409 2,427 2,572 2,698 2,532 2,819 2,908 3,080 3,213 3,491
Mental Health Clinic or Center 611 635 716 657 587 583 567 537 547 547 610 731 760 792 929 995 977 1,169 1,187
Partial Day Hospital or Day Treatment
   Program		 440 425 439 449 471 416 374 340 362 393 431 477 467 455 489 505 484 517 354
In-Home Therapist, Counselor, or Family
   Preservation Worker		 693 656 762 731 719 707 716 657 674 767 776 787 836 830 845 840 951 1,091 939
Inpatient or Residential1 509 542 629 619 596 581 539 524 531 526 547 574 606 642 737 708 683 701 510
Hospital 422 467 515 529 516 511 469 440 447 438 463 504 547 588 666 622 608 618 429
Residential Treatment Center 224 233 299 229 225 199 198 213 217 240 238 206 252 271 311 318 300 293 277
NONSPECIALTY MENTAL HEALTH
   SERVICE2		 nc nc nc nc nc nc nc 3,430 3,465 3,463 3,649 3,634 3,736 3,691 3,732 3,810 3,977 4,371 3,651
Education2,3 nc nc nc nc nc nc nc 2,931 2,957 2,920 3,157 3,147 3,229 3,206 3,193 3,231 3,444 3,727 3,136
School Social Worker, School Psychologist,
   or School Counselor		 nc nc nc nc nc nc nc 2,286 2,214 2,188 2,389 2,284 2,379 2,239 2,278 2,249 2,395 2,698 2,354
Special School or Program within a Regular
   School for Students with Emotional or
   Behavioral Problems		 nc nc nc nc nc nc nc 975 1,054 1,063 1,142 1,218 1,207 1,357 1,319 1,345 1,461 1,477 1,061
General Medicine                                      
Pediatrician or Other Family Doctor 657 732 840 810 694 692 710 605 601 619 629 686 700 668 708 805 767 902 762
Juvenile Justice                                      
Juvenile Detention Center, Prison, or Jail -- -- -- -- -- -- -- 109 80 103 83 59 63 53 53 45 48 49 22
Child Welfare                                      
Foster Care or Therapeutic Foster Care 157 179 158 143 129 114 118 92 108 140 96 99 92 79 108 92 94 97 66
SPECIALTY MENTAL HEALTH SERVICES
AND EDUCATION, GENERAL MEDICINE
OR CHILD WELFARE SERVICES1,2,3		 nc nc nc nc nc nc nc 1,226 1,283 1,328 1,397 1,490 1,457 1,408 1,513 1,615 1,706 1,910 1,678
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health service information were excluded. Questions on virtual services were added in Quarter 4 of 2020. Estimates in this table do not include data from these questions. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
1 Because of revisions in 2013 to Specialty Mental Health Service estimates, these 2002 to 2012 estimates may differ from estimates published prior to the 2013 NSDUH.
2 Because of revisions in 2009 to the questions on the Source of Youth Mental Health Education Services, these estimates are not comparable with the education services estimates published prior to the 2009 NSDUH.
3 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received mental health services from this setting.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2019, and Quarters 1 and 4, 2020.
210609
Table 11.1B – Settings Where Mental Health Services Were Received in Past Year: Among People Aged 12 to 17; Percentages, 2002-2020
Setting Where Mental Health Service
Was Received		 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
SPECIALTY MENTAL HEALTH SERVICE1 11.8 12.4 13.4 13.4 13.0 12.4 12.7 12.0 12.1 12.6 12.7 13.6 13.7 13.3 14.7 14.8 16.0 16.7 17.3
Outpatient 10.8 11.3 12.1 12.1 11.7 11.2 11.5 10.9 10.9 11.5 11.5 12.5 12.7 12.0 13.2 13.6 14.5 15.3 16.6
Private Therapist, Psychologist,
   Psychiatrist, Social Worker, or
   Counselor		 9.2 9.5 10.1 10.2 9.6 9.5 9.8 9.4 9.4 9.8 9.8 10.5 11.0 10.3 11.5 11.8 12.6 13.1 14.2
Mental Health Clinic or Center 2.5 2.6 2.9 2.6 2.3 2.3 2.3 2.2 2.3 2.2 2.5 3.0 3.1 3.2 3.8 4.0 4.0 4.8 4.8
Partial Day Hospital or Day Treatment
   Program		 1.8 1.7 1.8 1.8 1.9 1.7 1.5 1.4 1.5 1.6 1.7 1.9 1.9 1.8 2.0 2.0 2.0 2.1 1.4
In-Home Therapist, Counselor, or Family
   Preservation Worker		 2.8 2.6 3.0 2.9 2.9 2.8 2.9 2.7 2.8 3.1 3.1 3.2 3.4 3.4 3.4 3.4 3.9 4.5 3.8
Inpatient or Residential1 2.1 2.2 2.5 2.5 2.4 2.3 2.2 2.1 2.2 2.1 2.2 2.3 2.5 2.6 3.0 2.9 2.8 2.9 2.1
Hospital 1.7 1.9 2.1 2.1 2.0 2.0 1.9 1.8 1.8 1.8 1.9 2.0 2.2 2.4 2.7 2.5 2.5 2.5 1.7
Residential Treatment Center 0.9 0.9 1.2 0.9 0.9 0.8 0.8 0.9 0.9 1.0 1.0 0.8 1.0 1.1 1.3 1.3 1.2 1.2 1.1
NONSPECIALTY MENTAL HEALTH
   SERVICE2		 nc nc nc nc nc nc nc 14.2 14.5 14.2 15.0 15.0 15.4 15.2 15.4 15.7 16.5 18.1 15.0
Education2,3 nc nc nc nc nc nc nc 12.1 12.4 11.9 12.9 13.0 13.2 13.2 13.1 13.3 14.2 15.4 12.8
School Social Worker, School Psychologist,
   or School Counselor		 nc nc nc nc nc nc nc 9.4 9.2 8.9 9.7 9.4 9.7 9.2 9.3 9.2 9.9 11.1 9.6
Special School or Program within a Regular
   School for Students with Emotional or
   Behavioral Problems		 nc nc nc nc nc nc nc 4.0 4.4 4.3 4.7 5.0 4.9 5.6 5.4 5.5 6.0 6.1 4.3
General Medicine                                      
Pediatrician or Other Family Doctor 2.7 2.9 3.4 3.2 2.8 2.8 2.9 2.5 2.5 2.5 2.5 2.8 2.9 2.7 2.9 3.3 3.1 3.7 3.1
Juvenile Justice                                      
Juvenile Detention Center, Prison, or Jail -- -- -- -- -- -- -- 0.4 0.3 0.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.1
Child Welfare                                      
Foster Care or Therapeutic Foster Care 0.6 0.7 0.6 0.6 0.5 0.5 0.5 0.4 0.4 0.6 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.3
SPECIALTY MENTAL HEALTH SERVICES
AND EDUCATION, GENERAL MEDICINE
OR CHILD WELFARE SERVICES1,2,3		 nc nc nc nc nc nc nc 5.0 5.3 5.4 5.7 6.1 5.9 5.7 6.2 6.6 7.0 7.8 6.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health service information were excluded. Questions on virtual services were added in Quarter 4 of 2020. Estimates in this table do not include data from these questions. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
1 Because of revisions in 2013 to Specialty Mental Health Service estimates, these 2002 to 2012 estimates may differ from estimates published prior to the 2013 NSDUH.
2 Because of revisions in 2009 to the questions on the Source of Youth Mental Health Education Services, these estimates are not comparable with the education services estimates published prior to the 2009 NSDUH.
3 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received mental health services from this setting.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2019, and Quarters 1 and 4, 2020.
210609
Table 11.2A – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2004-2020
Demographic Characteristic 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 2,225 2,191 1,970 2,016 2,027 1,954 1,911 2,011 2,213 2,587 2,751 3,031 3,089 3,214 3,482 3,783 4,131
AGE GROUP                                  
12-13 445 417 383 337 366 330 330 312 420 470 548 587 548 516 632 816 902
14-15 783 811 684 705 706 741 706 710 844 1,025 986 1,163 1,115 1,200 1,250 1,341 1,533
16-17 997 964 902 974 955 883 876 989 950 1,091 1,217 1,281 1,427 1,498 1,600 1,626 1,696
GENDER                                  
Male 637 571 539 586 540 577 536 566 581 657 710 725 786 845 946 1,076 1,135
Female 1,588 1,620 1,431 1,430 1,487 1,377 1,375 1,446 1,632 1,930 2,042 2,306 2,303 2,369 2,537 2,708 2,996
HISPANIC ORIGIN AND RACE                                  
Not Hispanic or Latino 1,848 1,802 1,614 1,691 1,681 1,594 1,537 1,586 1,648 1,970 2,123 2,323 2,366 2,419 2,601 2,755 3,176
White 1,413 1,390 1,220 1,284 1,266 1,180 1,186 1,167 1,231 1,449 1,578 1,742 1,781 1,785 1,905 1,975 2,330
Black or African American 287 288 245 292 261 285 236 238 269 289 306 302 301 313 334 367 392
AIAN 13 10 12 7 13 9 10 15 7 7 11 * 16 24 23 20 *
NHOPI * * * * * * 1 * * * * * * * * * *
Asian 82 63 77 66 73 73 57 90 49 123 124 118 152 145 189 190 252
Two or More Races 51 41 52 41 59 41 48 75 81 95 93 121 109 138 137 189 179
Hispanic or Latino 377 389 356 325 347 360 374 425 566 617 628 708 724 795 882 1,028 956
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.2B – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2004-2020
Demographic Characteristic 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 9.0 8.8 7.9 8.2 8.3 8.1 8.0 8.2 9.1 10.7 11.4 12.5 12.8 13.3 14.4 15.7 17.0
AGE GROUP                                  
12-13 5.4 5.2 4.9 4.3 4.9 4.6 4.3 4.1 5.4 6.1 7.2 7.8 7.3 6.9 8.4 10.5 11.2
14-15 9.2 9.5 7.9 8.4 8.5 8.8 9.0 8.6 10.2 12.4 11.9 13.8 13.3 14.5 15.3 16.4 18.2
16-17 12.3 11.5 10.7 11.5 11.2 10.4 10.6 11.7 11.4 13.2 14.6 15.5 17.2 17.7 19.0 20.1 21.9
GENDER                                  
Male 5.0 4.5 4.2 4.6 4.3 4.7 4.4 4.5 4.7 5.3 5.7 5.8 6.4 6.8 7.7 8.8 9.2
Female 13.1 13.3 11.8 11.9 12.5 11.7 11.9 12.1 13.7 16.2 17.3 19.5 19.4 20.0 21.5 23.0 25.2
HISPANIC ORIGIN AND RACE                                  
Not Hispanic or Latino 8.9 8.7 7.9 8.4 8.5 8.2 8.1 8.3 8.7 10.4 11.3 12.5 12.8 13.1 14.2 15.2 17.5
White 9.2 9.1 8.2 8.7 8.8 8.4 8.6 8.6 9.1 10.9 12.0 13.4 13.8 14.0 15.1 15.9 18.7
Black or African American 7.7 7.6 6.4 7.8 7.1 7.9 6.8 7.0 7.9 8.6 9.1 9.0 9.1 9.5 10.3 11.4 12.9
AIAN 7.8 6.1 9.3 4.6 10.1 7.5 7.4 11.4 5.2 4.5 6.9 * 11.5 16.3 15.2 12.2 *
NHOPI * * * * * * 1.8 * * * * * * * * * *
Asian 8.3 6.0 7.7 6.6 7.7 7.6 5.5 7.6 4.2 10.2 10.4 9.7 11.9 11.3 13.6 15.1 13.9
Two or More Races 11.7 10.5 13.0 9.9 12.0 8.0 9.4 10.6 11.3 13.0 12.5 15.6 13.8 16.9 17.7 20.9 29.9
Hispanic or Latino 9.1 9.1 8.0 7.1 7.5 7.7 7.8 8.1 10.5 11.4 11.5 12.6 12.7 13.8 15.1 17.3 15.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.3A – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2006-2020
Demographic Characteristic 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 1,358 1,371 1,460 1,404 1,350 1,388 1,544 1,868 1,990 2,129 2,168 2,265 2,423 2,671 2,919
AGE GROUP                              
12-13 211 200 239 235 232 218 285 314 375 388 354 332 382 530 641
14-15 518 500 505 521 479 487 590 752 707 826 789 861 891 970 1,094
16-17 629 671 716 648 639 683 669 801 909 915 1,025 1,072 1,150 1,171 1,184
GENDER                              
Male 335 386 359 391 395 397 373 435 461 477 539 581 628 736 732
Female 1,023 986 1,101 1,013 954 991 1,172 1,432 1,529 1,652 1,629 1,684 1,795 1,935 2,187
HISPANIC ORIGIN AND RACE                              
Not Hispanic or Latino 1,118 1,141 1,226 1,150 1,093 1,113 1,152 1,425 1,540 1,651 1,703 1,694 1,841 1,981 2,230
White 871 873 944 858 853 799 883 1,046 1,167 1,258 1,290 1,256 1,354 1,415 1,616
Black or African American 150 193 171 204 157 183 164 207 214 198 196 233 225 256 294
AIAN 9 4 8 5 7 13 4 6 8 * 8 6 * 19 *
NHOPI * * * * * * * * * * * * * * *
Asian 54 39 44 48 44 60 30 98 80 67 118 101 127 142 186
Two or More Races 32 32 50 31 30 57 64 61 66 98 86 89 109 134 118
Hispanic or Latino 240 230 233 254 257 275 392 442 450 477 465 571 582 690 689
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019, and Quarters 1 and 4, 2020.
210609
Table 11.3B – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2006-2020
Demographic Characteristic 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 5.5 5.5 6.0 5.8 5.7 5.7 6.3 7.7 8.2 8.8 9.0 9.4 10.0 11.1 12.0
AGE GROUP                              
12-13 2.7 2.5 3.2 3.2 3.0 2.8 3.7 4.1 4.9 5.1 4.7 4.4 5.1 6.8 7.9
14-15 6.0 6.0 6.1 6.2 6.1 5.9 7.1 9.1 8.5 9.8 9.4 10.4 10.9 11.9 13.0
16-17 7.5 7.9 8.4 7.7 7.7 8.1 8.0 9.7 10.9 11.1 12.4 12.7 13.7 14.5 15.3
GENDER                              
Male 2.6 3.0 2.9 3.2 3.2 3.2 3.0 3.5 3.7 3.8 4.4 4.7 5.1 6.0 5.9
Female 8.4 8.2 9.3 8.6 8.2 8.3 9.8 12.0 13.0 14.0 13.7 14.2 15.2 16.5 18.4
HISPANIC ORIGIN AND RACE                              
Not Hispanic or Latino 5.5 5.7 6.2 5.9 5.7 5.8 6.1 7.6 8.2 8.9 9.2 9.2 10.1 11.0 12.3
White 5.8 5.9 6.5 6.1 6.2 5.9 6.5 7.8 8.9 9.7 10.0 9.8 10.7 11.4 13.0
Black or African American 3.9 5.1 4.6 5.7 4.5 5.4 4.8 6.2 6.4 5.9 6.0 7.1 6.9 8.0 9.7
AIAN 6.6 2.6 6.5 4.3 5.4 9.8 2.6 3.8 4.9 * 5.7 3.9 * 11.5 *
NHOPI * * * * * * * * * * * * * * *
Asian 5.3 3.9 4.7 5.0 4.3 5.0 2.6 8.1 6.6 5.5 9.3 7.9 9.2 11.3 10.3
Two or More Races 8.0 7.8 10.2 6.0 5.9 8.1 9.0 8.4 8.9 12.6 10.9 10.9 14.2 14.9 19.7
Hispanic or Latino 5.4 5.1 5.1 5.4 5.4 5.2 7.3 8.2 8.2 8.5 8.2 9.9 10.0 11.7 11.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019, and Quarters 1 and 4, 2020.
210609
Table 11.4A – Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; by Demographic Characteristics, Numbers in Thousands, 2004-2020
Demographic Characteristic 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 895 822 760 782 764 673 721 769 813 977 1,122 1,186 1,249 1,330 1,432 1,627 1,710
AGE GROUP                                  
12-13 169 136 133 137 122 98 106 112 127 181 194 185 189 193 251 302 *
14-15 278 329 263 259 236 244 271 258 307 376 394 472 455 453 514 585 629
16-17 448 357 364 386 405 331 343 400 379 420 535 530 605 684 667 740 675
GENDER                                  
Male 239 193 189 214 183 168 171 199 163 193 265 262 260 274 351 391 448
Female 656 629 571 568 581 505 549 570 650 784 857 924 989 1,056 1,081 1,236 1,262
HISPANIC ORIGIN AND RACE                                  
Not Hispanic or Latino 756 700 634 691 658 555 577 645 642 753 918 936 1,008 1,072 1,100 1,251 1,357
White 633 544 502 545 545 444 487 482 500 598 723 702 799 847 870 985 1,133
Black or African American 82 113 70 116 85 67 54 97 90 83 123 127 102 110 115 130 *
AIAN * * * * * * * * * * * * * * * * *
NHOPI * * * * * * * * * * * * * * * * *
Asian * * * * * * * * * * * * * * * * *
Two or More Races * * * * * * * * * * * 55 * 62 48 83 *
Hispanic or Latino 139 122 126 91 105 118 144 125 171 224 204 251 241 258 332 376 354
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.4B – Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; by Demographic Characteristics, Percentages, 2004-2020
Demographic Characteristic 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 40.3 37.8 38.8 39.0 37.7 34.6 37.8 38.4 37.0 38.1 41.2 39.3 40.9 41.5 41.4 43.3 41.6
AGE GROUP                                  
12-13 38.2 32.9 35.1 41.5 33.5 30.0 32.5 36.3 30.7 39.1 35.9 31.9 35.3 37.6 40.7 37.5 *
14-15 35.5 41.1 38.4 36.8 33.6 33.2 38.4 36.3 36.6 37.2 40.1 40.6 41.3 37.9 41.2 43.9 41.5
16-17 45.0 37.1 40.7 39.8 42.4 37.5 39.3 40.5 40.0 38.6 44.4 41.5 42.6 45.8 41.8 45.6 40.0
GENDER                                  
Male 37.7 34.1 35.3 36.7 34.0 29.2 32.0 35.3 28.3 29.7 37.7 36.3 33.5 32.5 37.5 36.8 39.7
Female 41.3 39.0 40.2 40.0 39.1 36.9 40.1 39.5 40.1 40.9 42.4 40.3 43.4 44.8 42.9 45.8 42.4
HISPANIC ORIGIN AND RACE                                  
Not Hispanic or Latino 41.0 39.0 39.5 41.1 39.3 35.0 37.6 40.7 39.0 38.5 43.5 40.5 42.9 44.4 42.6 45.7 43.1
White 44.9 39.3 41.3 42.7 43.1 37.7 41.1 41.4 40.7 41.6 46.1 40.6 45.1 47.5 46.1 50.3 49.1
Black or African American 28.9 39.3 29.1 39.7 32.4 23.9 23.0 41.0 33.5 28.6 40.6 42.0 34.5 35.1 34.6 35.6 *
AIAN * * * * * * * * * * * * * * * * *
NHOPI * * * * * * * * * * * * * * * * *
Asian * * * * * * * * * * * * * * * * *
Two or More Races * * * * * * * * * * * 46.7 * 44.8 34.8 44.4 *
Hispanic or Latino 36.8 31.8 35.9 28.2 30.4 33.0 38.4 29.4 30.8 36.9 33.1 35.5 34.1 32.7 37.9 36.8 37.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.5A – Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2006-2020
Demographic Characteristic 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 627 601 622 542 554 602 633 832 882 945 1,001 1,074 1,133 1,321 1,361
AGE GROUP                              
12-13 92 85 91 78 66 91 91 150 143 142 131 153 177 218 *
14-15 232 216 194 184 215 200 239 320 307 374 369 364 406 492 521
16-17 304 300 336 280 273 311 302 363 433 429 501 558 550 612 527
GENDER                              
Male 134 154 132 132 132 147 127 157 189 206 208 208 274 300 341
Female 493 447 489 410 422 455 506 675 693 739 793 866 859 1,021 1,020
HISPANIC ORIGIN AND RACE                              
Not Hispanic or Latino 535 534 550 443 448 502 506 645 725 755 827 868 882 1,018 1,088
White 432 439 461 352 380 379 403 504 572 563 668 679 695 800 917
Black or African American 53 72 65 58 42 82 56 72 99 97 71 97 90 108 *
AIAN * * * * * * * * * * * * * * *
NHOPI * * * * * * * * * * * * * * *
Asian * * * * * * * * * * * * * * *
Two or More Races * * * * * * * * * * * * * 63 *
Hispanic or Latino 92 67 72 99 106 100 127 187 158 190 174 206 251 304 273
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019, and Quarters 1 and 4, 2020.
210609
Table 11.5B – Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year; by Demographic Characteristics, Percentages, 2006-2020
Demographic Characteristic 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 46.5 43.9 42.6 38.8 41.1 43.5 41.0 45.0 44.7 44.6 46.7 47.5 46.9 49.7 46.9
AGE GROUP                              
12-13 44.1 42.3 38.3 33.8 28.7 42.3 32.0 48.5 38.7 37.0 37.6 46.2 47.2 41.9 *
14-15 44.8 43.2 38.6 35.6 45.0 41.0 40.5 43.2 43.4 45.4 47.5 42.3 45.6 50.8 48.1
16-17 48.8 44.9 46.9 43.2 42.7 45.5 45.4 45.3 48.1 47.1 49.2 52.0 47.8 52.3 44.8
GENDER                              
Male 40.1 40.2 36.9 34.0 33.4 37.3 34.4 36.4 41.2 43.1 39.0 35.8 43.7 41.2 46.6
Female 48.6 45.4 44.5 40.7 44.3 45.9 43.2 47.6 45.7 45.1 49.3 51.5 48.1 52.9 47.0
HISPANIC ORIGIN AND RACE                              
Not Hispanic or Latino 48.0 46.8 44.9 38.7 41.1 45.2 43.9 45.6 47.3 46.0 48.9 51.3 48.1 51.7 49.2
White 49.8 50.4 48.9 41.1 44.5 47.4 45.7 48.6 49.2 45.0 52.1 54.1 51.6 57.0 57.3
Black or African American 35.5 37.4 38.0 28.9 26.9 44.6 34.4 34.9 46.9 48.8 37.1 41.6 40.1 42.3 *
AIAN * * * * * * * * * * * * * * *
NHOPI * * * * * * * * * * * * * * *
Asian * * * * * * * * * * * * * * *
Two or More Races * * * * * * * * * * * * * 47.3 *
Hispanic or Latino 39.4 29.4 30.8 39.3 41.3 36.4 32.6 43.1 35.6 40.0 38.4 36.1 43.2 44.0 39.6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019, and Quarters 1 and 4, 2020.
210609
Table 11.6A – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; Numbers in Thousands, 2004-2020
Substance 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
PAST YEAR USE                                  
Illicit Drugs nc nc nc nc nc nc nc nc nc nc nc 955 979 942 1,138 1,207 1,183
Marijuana 601 553 483 473 485 472 481 523 547 664 664 675 751 724 878 930 908
Cocaine 66 73 64 69 61 43 46 54 53 28 41 34 35 37 35 29 38
Crack 15 12 16 17 12 9 9 11 7 2 11 * 4 2 0 10 *
Heroin 9 10 11 6 9 10 10 11 11 7 12 5 3 6 3 * *
Hallucinogens nc nc nc nc nc nc nc nc nc nc nc 129 127 145 112 147 152
LSD 36 38 18 16 28 43 24 30 40 29 48 63 41 72 62 99 89
PCP 21 16 11 8 20 12 8 12 9 6 11 2 6 12 6 7 *
Ecstasy nc nc nc nc nc nc nc nc nc nc nc 45 59 47 46 60 34
Inhalants nc nc nc nc nc nc nc nc nc nc nc 193 159 145 178 235 288
Methamphetamine nc nc nc nc nc nc nc nc nc nc nc 14 6 14 8 10 *
Misuse of Prescription Psychotherapeutics nc nc nc nc nc nc nc nc nc nc nc 370 411 369 375 355 229
Pain Relievers nc nc nc nc nc nc nc nc nc nc nc 236 283 210 214 158 94
Stimulants nc nc nc nc nc nc nc nc nc nc nc 166 142 158 126 184 115
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc nc nc 117 168 167 168 174 108
Tranquilizers nc nc nc nc nc nc nc nc nc nc nc 103 149 164 153 155 96
Sedatives nc nc nc nc nc nc nc nc nc nc nc 26 43 22 34 45 12
Benzodiazepines nc nc nc nc nc nc nc nc nc nc nc 96 142 154 145 149 81
Opioids nc nc nc nc nc nc nc nc nc nc nc 236 285 212 214 158 94
Central Nervous System Stimulants nc nc nc nc nc nc nc nc nc nc nc 181 164 173 158 200 140
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc nc nc 563 553 515 547 595 552
PAST MONTH USE                                  
Alcohol 632 606 523 553 509 473 460 482 503 490 556 524 508 524 558 638 673
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc nc nc 288 268 293 295 338 254
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc nc nc 51 52 39 22 53 49
Cigarette Use 508 450 378 388 354 336 302 317 284 288 254 241 239 214 212 166 110
Daily Cigarette Use 171 116 102 96 75 70 59 81 61 46 45 55 27 25 23 14 6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.6B – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; Percentages, 2004-2020
Substance 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
PAST YEAR USE                                  
Illicit Drugs nc nc nc nc nc nc nc nc nc nc nc 31.5 31.7 29.3 32.7 31.9 28.6
Marijuana 27.0 25.2 24.5 23.5 23.9 24.2 25.2 26.0 24.7 25.7 24.1 22.3 24.3 22.5 25.2 24.6 22.0
Cocaine 3.0 3.4 3.3 3.4 3.0 2.2 2.4 2.7 2.4 1.1 1.5 1.1 1.1 1.1 1.0 0.8 0.9
Crack 0.7 0.6 0.8 0.9 0.6 0.5 0.5 0.5 0.3 0.1 0.4 * 0.1 0.1 0.0 0.3 *
Heroin 0.4 0.4 0.5 0.3 0.4 0.5 0.5 0.5 0.5 0.3 0.4 0.2 0.1 0.2 0.1 * *
Hallucinogens nc nc nc nc nc nc nc nc nc nc nc 4.2 4.1 4.5 3.2 3.9 3.7
LSD 1.6 1.7 0.9 0.8 1.4 2.2 1.2 1.5 1.8 1.1 1.8 2.1 1.3 2.2 1.8 2.6 2.2
PCP 0.9 0.7 0.6 0.4 1.0 0.6 0.4 0.6 0.4 0.2 0.4 0.1 0.2 0.4 0.2 0.2 *
Ecstasy nc nc nc nc nc nc nc nc nc nc nc 1.5 1.9 1.5 1.3 1.6 0.8
Inhalants nc nc nc nc nc nc nc nc nc nc nc 6.4 5.1 4.5 5.1 6.2 7.0
Methamphetamine nc nc nc nc nc nc nc nc nc nc nc 0.5 0.2 0.4 0.2 0.3 *
Misuse of Prescription Psychotherapeutics nc nc nc nc nc nc nc nc nc nc nc 12.2 13.3 11.5 10.8 9.4 5.5
Pain Relievers nc nc nc nc nc nc nc nc nc nc nc 7.8 9.2 6.5 6.1 4.2 2.3
Stimulants nc nc nc nc nc nc nc nc nc nc nc 5.5 4.6 4.9 3.6 4.9 2.8
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc nc nc 3.9 5.5 5.2 4.8 4.6 2.6
Tranquilizers nc nc nc nc nc nc nc nc nc nc nc 3.4 4.8 5.1 4.4 4.1 2.3
Sedatives nc nc nc nc nc nc nc nc nc nc nc 0.8 1.4 0.7 1.0 1.2 0.3
Benzodiazepines nc nc nc nc nc nc nc nc nc nc nc 3.2 4.6 4.8 4.2 3.9 2.0
Opioids nc nc nc nc nc nc nc nc nc nc nc 7.8 9.2 6.6 6.1 4.2 2.3
Central Nervous System Stimulants nc nc nc nc nc nc nc nc nc nc nc 6.0 5.3 5.4 4.5 5.3 3.4
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc nc nc 18.6 17.9 16.0 15.7 15.7 13.4
PAST MONTH USE                                  
Alcohol 28.4 27.6 26.6 27.4 25.1 24.2 24.0 23.9 22.7 18.9 20.2 17.3 16.5 16.3 16.0 16.9 16.3
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc nc nc 9.5 8.7 9.1 8.5 8.9 6.2
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc nc nc 1.7 1.7 1.2 0.6 1.4 1.2
Cigarette Use 22.8 20.5 19.2 19.2 17.4 17.2 15.8 15.8 12.8 11.1 9.2 8.0 7.8 6.7 6.1 4.4 2.7
Daily Cigarette Use 7.7 5.3 5.2 4.8 3.7 3.6 3.1 4.0 2.7 1.8 1.6 1.8 0.9 0.8 0.7 0.4 0.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.7A – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year; Numbers in Thousands, 2006-2020
Substance 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
PAST YEAR USE                              
Illicit Drugs nc nc nc nc nc nc nc nc nc 774 757 720 885 932 791
Marijuana 362 339 384 366 327 375 414 495 510 545 572 547 678 718 618
Cocaine 47 54 48 35 35 36 45 17 32 32 30 27 27 29 27
Crack 10 17 5 6 7 11 7 2 6 * 4 2 0 10 *
Heroin 9 6 8 6 9 8 11 7 12 2 3 4 3 * *
Hallucinogens nc nc nc nc nc nc nc nc nc 116 102 122 96 133 126
LSD 13 13 23 30 20 23 36 19 45 56 31 58 52 87 70
PCP 10 5 16 6 4 7 8 6 11 2 6 11 6 7 *
Ecstasy nc nc nc nc nc nc nc nc nc 43 46 42 42 56 14
Inhalants nc nc nc nc nc nc nc nc nc 151 124 119 145 178 179
Methamphetamine nc nc nc nc nc nc nc nc nc 10 5 14 6 10 *
Misuse of Prescription Psychotherapeutics nc nc nc nc nc nc nc nc nc 325 349 285 301 301 188
Pain Relievers nc nc nc nc nc nc nc nc nc 201 237 170 172 136 70
Stimulants nc nc nc nc nc nc nc nc nc 148 130 122 106 157 100
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc 103 148 131 151 147 100
Tranquilizers nc nc nc nc nc nc nc nc nc 89 131 127 136 129 88
Sedatives nc nc nc nc nc nc nc nc nc 25 41 19 30 43 12
Benzodiazepines nc nc nc nc nc nc nc nc nc 82 125 119 129 124 73
Opioids nc nc nc nc nc nc nc nc nc 201 238 172 172 136 70
Central Nervous System Stimulants nc nc nc nc nc nc nc nc nc 163 145 133 128 174 114
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc 477 450 406 435 482 386
PAST MONTH USE                              
Alcohol 386 404 385 372 318 331 370 365 421 396 373 398 433 487 477
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc 228 199 220 238 262 200
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc 49 40 29 17 43 45
Cigarette Use 290 285 275 276 219 225 217 221 203 213 194 168 177 129 79
Daily Cigarette Use 83 75 56 55 46 58 44 32 40 50 19 18 17 12 6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019, and Quarters 1 and 4, 2020.
210609
Table 11.7B – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year; Percentages, 2006-2020
Substance 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
PAST YEAR USE                              
Illicit Drugs nc nc nc nc nc nc nc nc nc 36.3 34.9 31.8 36.5 34.9 27.1
Marijuana 26.6 24.7 26.3 26.0 24.3 27.0 26.8 26.5 25.6 25.6 26.4 24.1 28.0 26.9 21.2
Cocaine 3.5 4.0 3.3 2.5 2.6 2.6 2.9 0.9 1.6 1.5 1.4 1.2 1.1 1.1 0.9
Crack 0.8 1.2 0.4 0.5 0.5 0.8 0.4 0.1 0.3 * 0.2 0.1 0.0 0.4 *
Heroin 0.6 0.5 0.6 0.4 0.6 0.6 0.7 0.4 0.6 0.1 0.1 0.2 0.1 * *
Hallucinogens nc nc nc nc nc nc nc nc nc 5.5 4.7 5.4 4.0 5.0 4.3
LSD 0.9 0.9 1.6 2.1 1.5 1.7 2.3 1.0 2.2 2.6 1.4 2.6 2.1 3.3 2.4
PCP 0.8 0.4 1.1 0.4 0.3 0.5 0.5 0.3 0.5 0.1 0.3 0.5 0.2 0.3 *
Ecstasy nc nc nc nc nc nc nc nc nc 2.0 2.1 1.9 1.7 2.1 0.5
Inhalants nc nc nc nc nc nc nc nc nc 7.1 5.7 5.2 6.0 6.7 6.1
Methamphetamine nc nc nc nc nc nc nc nc nc 0.5 0.2 0.6 0.3 0.4 *
Misuse of Prescription Psychotherapeutics nc nc nc nc nc nc nc nc nc 15.3 16.1 12.6 12.4 11.3 6.4
Pain Relievers nc nc nc nc nc nc nc nc nc 9.4 10.9 7.5 7.1 5.1 2.4
Stimulants nc nc nc nc nc nc nc nc nc 6.9 6.0 5.4 4.4 5.9 3.4
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc 4.8 6.8 5.8 6.2 5.5 3.4
Tranquilizers nc nc nc nc nc nc nc nc nc 4.2 6.0 5.6 5.6 4.8 3.0
Sedatives nc nc nc nc nc nc nc nc nc 1.2 1.9 0.8 1.2 1.6 0.4
Benzodiazepines nc nc nc nc nc nc nc nc nc 3.8 5.8 5.2 5.3 4.6 2.5
Opioids nc nc nc nc nc nc nc nc nc 9.4 11.0 7.6 7.1 5.1 2.4
Central Nervous System Stimulants nc nc nc nc nc nc nc nc nc 7.6 6.7 5.9 5.3 6.5 3.9
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc 22.4 20.8 17.9 18.0 18.0 13.2
PAST MONTH USE                              
Alcohol 28.4 29.5 26.4 26.5 23.6 23.8 24.0 19.5 21.1 18.6 17.2 17.6 17.9 18.2 16.3
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc 10.7 9.2 9.7 9.8 9.8 6.9
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc 2.3 1.8 1.3 0.7 1.6 1.5
Cigarette Use 21.3 20.8 18.8 19.7 16.2 16.2 14.1 11.8 10.2 10.0 8.9 7.4 7.3 4.8 2.7
Daily Cigarette Use 6.1 5.5 3.8 3.9 3.4 4.2 2.9 1.7 2.0 2.3 0.9 0.8 0.7 0.5 0.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019, and Quarters 1 and 4, 2020.
210609
Table 11.8A – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with No Major Depressive Episode in Past Year; Numbers in Thousands, 2004-2020
Substance 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
PAST YEAR USE                                  
Illicit Drugs nc nc nc nc nc nc nc nc nc nc nc 3,251 2,823 3,010 2,888 2,926 2,158
Marijuana 2,998 2,763 2,803 2,629 2,693 2,810 2,836 2,962 2,746 2,561 2,479 2,366 2,136 2,283 2,164 2,256 1,582
Cocaine 335 335 337 302 238 196 178 165 123 93 115 115 91 87 66 67 46
Crack 44 37 57 45 22 18 9 18 12 7 5 5 4 14 1 2 2
Heroin 37 23 26 15 27 25 18 36 20 20 13 14 9 7 5 * *
Hallucinogens nc nc nc nc nc nc nc nc nc nc nc 371 308 346 254 279 212
LSD 117 108 86 108 150 97 103 113 106 108 163 177 157 173 136 171 124
PCP 47 64 47 48 40 35 26 26 36 20 22 29 12 10 7 14 *
Ecstasy nc nc nc nc nc nc nc nc nc nc nc 151 111 121 80 78 50
Inhalants nc nc nc nc nc nc nc nc nc nc nc 457 378 418 460 476 365
Methamphetamine nc nc nc nc nc nc nc nc nc nc nc 22 23 31 32 28 11
Misuse of Prescription Psychotherapeutics nc nc nc nc nc nc nc nc nc nc nc 1,044 851 824 767 643 427
Pain Relievers nc nc nc nc nc nc nc nc nc nc nc 700 556 526 444 358 284
Stimulants nc nc nc nc nc nc nc nc nc nc nc 305 275 280 231 230 153
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc nc nc 315 285 313 275 239 101
Tranquilizers nc nc nc nc nc nc nc nc nc nc nc 277 260 282 253 214 85
Sedatives nc nc nc nc nc nc nc nc nc nc nc 73 50 50 29 34 17
Benzodiazepines nc nc nc nc nc nc nc nc nc nc nc 260 250 280 243 212 71
Opioids nc nc nc nc nc nc nc nc nc nc nc 710 563 526 448 358 284
Central Nervous System Stimulants nc nc nc nc nc nc nc nc nc nc nc 397 340 350 292 281 186
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc nc nc 1,610 1,335 1,373 1,284 1,181 891
PAST MONTH USE                                  
Alcohol 3,741 3,515 3,635 3,413 3,088 3,114 2,793 2,759 2,660 2,316 2,219 1,823 1,726 1,862 1,618 1,658 1,358
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc nc nc 1,127 901 990 843 837 765
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc nc nc 165 132 129 105 146 89
Cigarette Use 2,420 2,221 2,214 2,047 1,858 1,825 1,659 1,557 1,294 1,042 900 755 574 538 427 368 228
Daily Cigarette Use 628 568 583 527 417 433 388 349 285 212 229 141 94 68 73 55 19
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.8B – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with No Major Depressive Episode in Past Year; Percentages, 2004-2020
Substance 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
PAST YEAR USE                                  
Illicit Drugs nc nc nc nc nc nc nc nc nc nc nc 15.3 13.4 14.3 14.0 14.4 10.7
Marijuana 13.3 12.1 12.2 11.6 12.0 12.7 12.9 13.2 12.4 11.8 11.6 11.1 10.1 10.9 10.5 11.1 7.9
Cocaine 1.5 1.5 1.5 1.3 1.1 0.9 0.8 0.7 0.6 0.4 0.5 0.5 0.4 0.4 0.3 0.3 0.2
Crack 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0
Heroin 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 * *
Hallucinogens nc nc nc nc nc nc nc nc nc nc nc 1.7 1.5 1.6 1.2 1.4 1.1
LSD 0.5 0.5 0.4 0.5 0.7 0.4 0.5 0.5 0.5 0.5 0.8 0.8 0.7 0.8 0.7 0.8 0.6
PCP 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 *
Ecstasy nc nc nc nc nc nc nc nc nc nc nc 0.7 0.5 0.6 0.4 0.4 0.2
Inhalants nc nc nc nc nc nc nc nc nc nc nc 2.2 1.8 2.0 2.2 2.3 1.8
Methamphetamine nc nc nc nc nc nc nc nc nc nc nc 0.1 0.1 0.1 0.2 0.1 0.1
Misuse of Prescription Psychotherapeutics nc nc nc nc nc nc nc nc nc nc nc 4.9 4.0 3.9 3.7 3.2 2.1
Pain Relievers nc nc nc nc nc nc nc nc nc nc nc 3.3 2.6 2.5 2.2 1.8 1.4
Stimulants nc nc nc nc nc nc nc nc nc nc nc 1.4 1.3 1.3 1.1 1.1 0.8
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc nc nc 1.5 1.3 1.5 1.3 1.2 0.5
Tranquilizers nc nc nc nc nc nc nc nc nc nc nc 1.3 1.2 1.3 1.2 1.1 0.4
Sedatives nc nc nc nc nc nc nc nc nc nc nc 0.3 0.2 0.2 0.1 0.2 0.1
Benzodiazepines nc nc nc nc nc nc nc nc nc nc nc 1.2 1.2 1.3 1.2 1.0 0.4
Opioids nc nc nc nc nc nc nc nc nc nc nc 3.3 2.7 2.5 2.2 1.8 1.4
Central Nervous System Stimulants nc nc nc nc nc nc nc nc nc nc nc 1.9 1.6 1.7 1.4 1.4 0.9
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc nc nc 7.6 6.3 6.5 6.2 5.8 4.4
PAST MONTH USE                                  
Alcohol 16.5 15.4 15.8 15.0 13.8 14.1 12.8 12.3 12.0 10.7 10.3 8.6 8.2 8.9 7.8 8.2 6.7
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc nc nc 5.3 4.3 4.7 4.1 4.1 3.8
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc nc nc 0.8 0.6 0.6 0.5 0.7 0.4
Cigarette Use 10.7 9.8 9.7 9.0 8.3 8.2 7.6 7.0 5.8 4.8 4.2 3.6 2.7 2.6 2.1 1.8 1.1
Daily Cigarette Use 2.8 2.5 2.5 2.3 1.9 2.0 1.8 1.6 1.3 1.0 1.1 0.7 0.4 0.3 0.4 0.3 0.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.9A – Type of Treatment Received in Past Year for Depression: Among People Aged 12 to 17 with Major Depressive Episode (MDE) in Past Year and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year; Numbers in Thousands, 2004-2020
MDE/Type of Treatment 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
MDE                                  
Saw or Talked to a Health Professional
OR Used Prescription Medication		 856 778 700 739 731 638 682 724 791 944 1,076 1,139 1,223 1,286 1,371 1,577 1,685
Saw or Talked to a Health Professional
   BUT Did Not Use Prescription Medication		 425 404 407 372 406 358 370 397 431 522 543 596 571 625 749 796 928
Used Prescription Medication BUT Did Not
   See or Talk to a Health Professional		 76 58 47 53 60 46 58 52 52 94 75 87 59 76 77 127 53
Saw or Talked to a Health Professional
   AND Used Prescription Medication		 342 308 241 307 259 231 252 272 302 316 447 447 576 570 533 645 691
MDE with Severe Impairment                                  
Saw or Talked to a Health Professional
OR Used Prescription Medication		 -- -- 575 574 598 515 528 570 618 808 851 924 986 1,044 1,094 1,287 1,344
Saw or Talked to a Health Professional
   BUT Did Not Use Prescription
   Medication		 -- -- 314 281 313 283 280 303 309 421 423 468 413 477 575 622 724
Used Prescription Medication BUT
   Did Not See or Talk to a Health
   Professional		 -- -- 37 39 49 37 34 33 43 86 63 66 48 54 55 99 38
Saw or Talked to a Health Professional
   AND Used Prescription Medication		 -- -- 220 249 232 191 212 232 260 287 360 386 513 505 455 560 570
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.9B – Type of Treatment Received in Past Year for Depression: Among People Aged 12 to 17 with Major Depressive Episode (MDE) in Past Year and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year; Percentages, 2004-2020
MDE/Type of Treatment 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
MDE                                  
Saw or Talked to a Health Professional
OR Used Prescription Medication		 38.7 35.9 35.9 37.0 36.3 33.0 35.8 36.3 36.0 36.9 39.6 37.9 40.2 40.3 40.0 42.2 41.2
Saw or Talked to a Health Professional
   BUT Did Not Use Prescription Medication		 19.3 18.6 20.9 18.6 20.2 18.5 19.4 19.9 19.6 20.4 20.0 19.8 18.8 19.6 21.8 21.3 22.6
Used Prescription Medication BUT Did Not
   See or Talk to a Health Professional		 3.4 2.7 2.4 2.7 3.0 2.4 3.0 2.6 2.4 3.7 2.8 2.9 1.9 2.4 2.2 3.4 1.3
Saw or Talked to a Health Professional
   AND Used Prescription Medication		 15.5 14.1 12.3 15.3 12.8 11.9 13.2 13.6 13.7 12.3 16.4 14.8 18.9 17.9 15.4 17.1 16.8
MDE with Severe Impairment                                  
Saw or Talked to a Health Professional
OR Used Prescription Medication		 -- -- 42.9 42.1 41.1 37.0 39.3 41.3 40.2 43.8 43.2 43.7 46.1 46.2 45.5 48.7 46.6
Saw or Talked to a Health Professional
   BUT Did Not Use Prescription
   Medication		 -- -- 23.4 20.6 21.5 20.3 20.8 21.9 20.1 22.9 21.5 22.1 19.3 21.1 24.0 23.5 24.9
Used Prescription Medication BUT
   Did Not See or Talk to a Health
   Professional		 -- -- 2.7 2.9 3.3 2.7 2.5 2.4 2.8 4.7 3.2 3.1 2.3 2.4 2.3 3.7 1.3
Saw or Talked to a Health Professional
   AND Used Prescription Medication		 -- -- 16.4 18.3 15.9 13.7 15.7 16.7 16.9 15.6 18.2 18.2 24.0 22.4 18.9 21.0 19.6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.

Go to Top of PageGo to the Table of Contents